COMP <GO>
QTTB vs MRK // FREE CASH FLOW YIELD
Q32 Bio Inc. (NASDAQ) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: QTTB 5
— MRK 6
▲ FREE CASH FLOW YIELD LEADER: MRK
LAST: $8.87 (-2.10%) • MKT CAP: $264.1M
fcf-yield
-12.70%
LAST: $146.33 (+3.83%) • MKT CAP: $361.02B
fcf-yield
3.42%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (QTTB VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | QTTB | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 74.80% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 85.00% | 20.70% | +64.30 | QTTB | /roic <GO> |
| EV/EBITDA & P/E Valuation | 12.8x | 15.3x | -2.50 | QTTB | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | -12.70% | 3.42% | -16.12 | MRK | /fcf-yield <GO> |
| Operating Margin | 31.50% | 34.30% | -2.80 | MRK | /operating-margins <GO> |
| Net Profit Margin | 55.50% | 28.10% | +27.40 | QTTB | /net-margins <GO> |
| Revenue Growth (YoY) | — | 1.30% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.99 | 5.19 | +0.80 | QTTB | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 7/9 | -3.00 | MRK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.6 | 51.7 | -4.10 | MRK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.92 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 8.3x | 18.4x | -10.10 | QTTB | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $264.1M | $361.02B | -$360.76B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | QTTB REV | MRK REV | QTTB GROSS % | MRK GROSS % | QTTB FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $53.7M | $65.01B | — | 74.8% | -$33.5M | $12.36B |
| FY 2024 | $0 | $64.17B | — | 76.3% | -$67.8M | $18.10B |
| FY 2023 | $1.2M | $60.12B | — | — | -$18.7M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
QTTB // BETA —
MRK // BETA 0.92